Synaptically-competent neurons derived from canine embryonic stem cells by lineage selection with EGF and noggin

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Wilcox, Jared T ^a,b   Lai, Jonathan K Y ^a   Semple, Esther ^a   Brisson, Brigitte A ^a   Gartley, Cathy ^a   Armstrong, John N ^a   Betts, Dean H ^a,c  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMPA RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; EPIDERMAL GROWTH FACTOR; NOGGIN; PLATELET DERIVED GROWTH FACTOR AA; RETINOIC ACID; TRANSCRIPTION FACTOR SOX2; BIOLOGICAL MARKER; CARRIER PROTEIN; NOGGIN PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL LINEAGE; CELL RENEWAL; COCULTURE; CONTROLLED STUDY; DOG; ELECTROPHYSIOLOGY; EMBRYO; EMBRYONIC STEM CELL; FETUS; FETUS CELL; GENE; GENE EXPRESSION PROFILING; MAP2 GENE; NERVE CELL; NERVE CELL DIFFERENTIATION; NESTIN GENE; NEURAL STEM CELL; NONHUMAN; PSD95 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STX1A GENE; SYNAPSE; SYNPR GENE; TUBB3 GENE; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CELL SHAPE; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; MOUSE;

ANIMALIA; CANIS FAMILIARIS;

ANIMALS; ASTROCYTES; BIOLOGICAL MARKERS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL SHAPE; COCULTURE TECHNIQUES; DOGS; EMBRYONIC STEM CELLS; EPIDERMAL GROWTH FACTOR; HUMANS; MICE; NEURAL STEM CELLS; NEURONS; SYNAPSES; TRETINOIN;

EID: 79956096916     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019768     Document Type: Article

References (63)

1. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, Hill CE, Sparling JS, et al. (2010) A Systematic Review of Cellular Transplantation Therapies for Spinal Cord Injury. Journal of neurotrauma.
2. Geisler FH, Coleman WP, Grieco G, Poonian D, Group SS, (2001) The Sygen multicenter acute spinal cord injury study. Spine 26: S87-98.
3. Ikonomidou C, Turski L, (2002) Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 1: 383-386.
4. Samson K, (2010) NerveCenter: Phase III Alzheimer trial halted: Search for therapeutic biomarkers continues. Ann Neurol 68: A9-A12.
5. Miller G, (2010) Pharmacology. The puzzling rise and fall of a dark-horse Alzheimer's drug. Science 327: 1309.
6. Marler JR, (2007) NINDS clinical trials in stroke: lessons learned and future directions. Stroke 38: 3302-3307.
7. Bracken MB, (2001) Methylprednisolone and acute spinal cord injury: an update of the randomized evidence. Spine 26: S47-54.
8. Fiester A, Scholer H, Caplan A, (2004) Stem cell therapies: time to talk to the animals. Cloning Stem Cells 6: 3-4.
9. Tecirlioglu RT, Trounson AO, (2007) Embryonic stem cells in companion animals (horses, dogs and cats): present status and future prospects. Reprod Fertil Dev 19: 740-747.
10. Schneider MR, Wolf E, Braun J, Kolb H-J, Adler H, (2009) Canine embryonic stem cells: State of the art. Theriogenology pp. 1-6.
11. Wayne RK, Ostrander EA, (2007) Lessons learned from the dog genome. Trends Genet 23: 557-567.
12. Neff MW, Rine J, (2006) A fetching model organism. Cell 124: 229-231.
13. Jeffery ND, Smith PM, Lakatos A, Ibanez C, Ito D, et al. (2006) Clinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy. Spinal Cord 44: 584-593.
14. Wewetzer K, Radtke C, Kocsis J, Baumgartner W, (2010) Species-specific control of cellular proliferation and the impact of large animal models for the use of olfactory ensheathing cells and Schwann cells in spinal cord repair. Exp Neurol.
15. Techangamsuwan S, Imbschweiler I, Kreutzer R, Kreutzer M, Baumgartner W, et al. (2008) Similar behaviour and primate-like properties of adult canine Schwann cells and olfactory ensheathing cells in long-term culture. Brain Res 1240: 31-38.
16. Lim JH, Byeon YE, Ryu HH, Jeong YH, Lee YW, et al. (2007) Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs. J Vet Sci 8: 275-282.
17. Hiyama A, Mochida J, Iwashina T, Omi H, Watanabe T, et al. (2008) Transplantation of mesenchymal stem cells in a canine disc degeneration model. J Orthop Res 26: 589-600.
18. Jeffery ND, Lakatos A, Franklin RJ, (2005) Autologous olfactory glial cell transplantation is reliable and safe in naturally occurring canine spinal cord injury. J Neurotrauma 22: 1282-1293.
19. Smith PM, Lakatos A, Barnett SC, Jeffery ND, Franklin RJ, (2002) Cryopreserved cells isolated from the adult canine olfactory bulb are capable of extensive remyelination following transplantation into the adult rat CNS. Exp Neurol 176: 402-406.
20. Lee S-H, Chung Y-N, Kim Y-H, Kim Y-J, Park J-P, et al. (2009) Effects of human neural stem cell transplantation in canine spinal cord hemisection. Neurol Res 31: 996-1002.
21. Kim BG, Kang YM, Phi JH, Kim YH, Hwang DH, et al. (2010) Implantation of polymer scaffolds seeded with neural stem cells in a canine spinal cord injury model. Cytotherapy 12: 841-845.
22. Bruce CW, Brisson BA, Gyselinck K, (2008) Spinal fracture and luxation in dogs and cats: a retrospective evaluation of 95 cases. Vet Comp Orthop Traumatol 21: 280-284.
23. Hu R, Zhou J, Luo C, Lin J, Wang X, et al. (2010) Glial scar and neuroregeneration: histological, functional, and magnetic resonance imaging analysis in chronic spinal cord injury. J Neurosurg Spine 13: 169-180.
24. Wilcox JT, Semple E, Gartley C, Brisson BA, Perrault SD, et al. (2009) Characterization of canine embryonic stem cell lines derived from different niche microenvironments. Stem Cells Dev 18: 1167-1178.
25. Schneider MR, Adler H, Braun J, Kienzle B, Wolf E, et al. (2007) Canine embryo-derived stem cells-toward clinically relevant animal models for evaluating efficacy and safety of cell therapies. Stem Cells 25: 1850-1851.
26. Vaags AK, Rosic-Kablar S, Gartley CJ, Zheng YZ, Chesney A, et al. (2009) Derivation and characterization of canine embryonic stem cell lines with in vitro and in vivo differentiation potential. Stem Cells 27: 329-340.
27. Reynolds BA, Weiss S, (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707-1710.
28. Song HJ, Stevens CF, Gage FH, (2002) Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons. Nat Neurosci 5: 438-445.
29. Kallur T, Darsalia V, Lindvall O, Kokaia Z, (2006) Human fetal cortical and striatal neural stem cells generate region-specific neurons in vitro and differentiate extensively to neurons after intrastriatal transplantation in neonatal rats. J Neurosci Res 84: 1630-1644.
30. Ying QL, Stavridis M, Griffiths D, Li M, Smith A, (2003) Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 21: 183-186.
31. Gerrard L, Rodgers L, Cui W, (2005) Differentiation of human embryonic stem cells to neural lineages in adherent culture by blocking bone morphogenetic protein signaling. Stem Cells 23: 1234-1241.
32. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, et al. (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27: 275-280.
33. Smukler SR, Runciman SB, Xu S, van der Kooy D, (2006) Embryonic stem cells assume a primitive neural stem cell fate in the absence of extrinsic influences. J Cell Biol 172: 79-90.
34. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI, (1995) Embryonic stem cells express neuronal properties in vitro. Dev Biol 168: 342-357.
35. Johnson PJ, Tatara A, Shiu A, Sakiyama-Elbert SE, (2010) Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant 19: 89-101.
36. Hu BY, Du ZW, Zhang SC, (2009) Differentiation of human oligodendrocytes from pluripotent stem cells. Nat Protoc 4: 1614-1622.
37. Dhara SK, Stice SL, (2008) Neural differentiation of human embryonic stem cells. J Cell Biochem 105: 633-640.
38. Roybon L, Ma Z, Asztely F, Fosum A, Jacobsen SE, et al. (2006) Failure of transdifferentiation of adult hematopoietic stem cells into neurons. Stem Cells 24: 1594-1604.
39. Hofstetter CP, Holmström NAV, Lilja JA, Schweinhardt P, Hao J, et al. (2005) Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nature Neuroscience 8: 346-353.
40. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Schut D, Fehlings MG, (2010) Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J Neurosci 30: 1657-1676.
41. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, et al. (2005) Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25: 4694-4705.
42. Bendall SC, Stewart MH, Menendez P, George D, Vijayaragavan K, et al. (2007) IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448: 1015-1021.
43. Yao M, Bain G, Gottlieb DI, (1995) Neuronal differentiation of P19 embryonal carcinoma cells in defined media. J Neurosci Res 41: 792-804.
44. Lamb TM, Knecht AK, Smith WC, Stachel SE, Economides AN, et al. (1993) Neural induction by the secreted polypeptide noggin. Science 262: 713-718.
45. Weiss S, Dunne C, Hewson J, Wohl C, Wheatley M, et al. (1996) Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci 16: 7599-7609.
46. Pera MF, Andrade J, Houssami S, Reubinoff B, Trounson A, et al. (2004) Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J Cell Sci 117: 1269-1280.
47. Liour SS, Kraemer SA, Dinkins MB, Su CY, Yanagisawa M, et al. (2006) Further characterization of embryonic stem cell-derived radial glial cells. Glia 53: 43-56.
48. Conti L, Cattaneo E, (2010) Neural stem cell systems: physiological players or in vitro entities? Nat Rev Neurosci pp. 1-12.
49. Itsykson P, Ilouz N, Turetsky T, Goldstein RS, Pera MF, et al. (2005) Derivation of neural precursors from human embryonic stem cells in the presence of noggin. Mol Cell Neurosci 30: 24-36.
50. Dottori M, Pera MF, (2008) Neural differentiation of human embryonic stem cells. Methods Mol Biol 438: 19-30.
51. Rieske P, Krynska B, Azizi SA, (2005) Human fibroblast-derived cell lines have characteristics of embryonic stem cells and cells of neuro-ectodermal origin. Differentiation 73: 474-483.
52. Iwanami A, Kaneko S, Nakamura M, Kanemura Y, Mori H, et al. (2005) Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res 80: 182-190.
53. Lee SH, Chung YN, Kim YH, Kim YJ, Park JP, et al. (2009) Effects of human neural stem cell transplantation in canine spinal cord hemisection. Neurol Res 31: 996-1002.
54. Brisson BA, (2010) Intervertebral disc disease in dogs. Vet Clin North Am Small Anim Pract 40: 829-858.
55. Shimada H, Nakada A, Hashimoto Y, Shigeno K, Shionoya Y, et al. (2010) Generation of canine induced pluripotent stem cells by retroviral transduction and chemical inhibitors. Mol Reprod Dev 77: 2.
56. Ellis J, Bruneau BG, Keller G, Lemischka IR, Nagy A, et al. (2009) Alternative induced pluripotent stem cell characterization criteria for in vitro applications. Cell Stem Cell 4: 198-199; author reply 202.
57. Maherali N, Hochedlinger K, (2008) Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3: 595-605.
58. Rabinowitz RS, Eck JC, Harper CM Jr, Larson DR, Jimenez MA, et al. (2008) Urgent surgical decompression compared to methylprednisolone for the treatment of acute spinal cord injury: a randomized prospective study in beagle dogs. Spine (Phila Pa 1976) 33: 2260-2268.
59. Kang SM, Cho MS, Seo H, Yoon CJ, Oh SK, et al. (2007) Efficient induction of oligodendrocytes from human embryonic stem cells. Stem Cells 25: 419-424.
60. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
61. Murphy CL, Polak JM, (2002) Differentiating embryonic stem cells: GAPDH, but neither HPRT nor beta-tubulin is suitable as an internal standard for measuring RNA levels. Tissue Eng 8: 551-559.
62. Bustin SA, Benes V, Nolan T, Pfaffl MW, (2005) Quantitative real-time RT-PCR-a perspective. J Mol Endocrinol 34: 597-601.
63. Armstrong JN, Saganich MJ, Xu NJ, Henkemeyer M, Heinemann SF, et al. (2006) B-ephrin reverse signaling is required for NMDA-independent long-term potentiation of mossy fibers in the hippocampus. J Neurosci 26: 3474-3481.